Comparative study of management strategies for immune checkpoint inhibitor‐induced inflammatory arthritis: rheumatologists versus oncologists
RA-like ir-IA comprised 8% of ICI-related irAEs. During the study period, patients managed by rheumatologists received lower initial prednisolone doses and more frequent csDMARD than oncologists. A multidisciplinary involvement between rheumatologists and oncologists in the event of ir-IA is crucial.
Authors
- Frances Zhao
- Ravini De Silva
- Matthew Terrill (ORCID: https://orcid.org/0000-0002-9393-2987)
- Hajira Masood (ORCID: https://orcid.org/0009-0001-6887-2900)
- Ranjeny Thomas (ORCID: https://orcid.org/0000-0002-0518-8386)
- Victoria Atkinson (ORCID: https://orcid.org/0000-0002-9806-9019)
- Ji-Hyang Yoon (ORCID: https://orcid.org/0000-0002-4953-0489)
- Jessie Binns
Institutions
- The University of Queensland (AU)
- Princess Alexandra Hospital (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1111/imj.16629
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05